Correction to: Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer

Corrections are needed to the original version of this article. In Table 2, the “Odds ratio” of the variables “Lower lobe vs. Upper lobe” and “≥26 vs.<26 ” should be 2.250 instead of 2250 and 2.250 instead of 2.25.

http://link.springer.com/10.1007/s10637-020-00969-4

Source: Investigational New Drugs - June 25, 2020 Category: Drugs & Pharmacology Source Type: research